The aim of our study was to determine the incidence, characteristics, and clinical outcomes of patients with the novel coronavirus (COVID-19) infection who had presented with and been treated for acute limb ischemia (ALI) during the 2020 coronavirus pandemic…
DettagliThe recent Sars-Cov-2 pandemic (COVID-19) has led to growing research to explain the poor clinical prognosis in some patients…
DettagliCOVID-19, a disease initially thought to be prominently an interstitial pneumonia with varying degrees of severity, can be considered a vascular disease with regards to serious complications and causes of mortality…
DettagliReports are emerging regarding the association of acute ischemic strokes with large vessel occlusion and coronavirus disease 2019 (COVID-19). While a higher severity of these patients could be expected from the addition of both respiratory and neurological injury, COVID-19 patients with strokes can present with mild or none respiratory symptoms…
DettagliCoronavirus disease 2019 (COVID-19) is associated with a severe inflammatory response. Inflammation affects atherosclerotic plaque vulnerability and promotes a thrombogenic environment. We report a series of 6 patients with COVID-19 with acute ischemic stroke due to intraluminal carotid artery thrombus presenting during an 8-day period…
DettagliRecent studies suggest that thrombotic complications are a common phenomenon in the novel SARS-CoV-2 infection. The main objective of our study is to assess cumulative incidence of pulmonary embolism (PE) in non critically ill COVID-19 patients and to identify its predicting factors associated to the diagnosis of pulmonary embolism…
DettagliA remarkably high incidence of VTE has been reported among critically ill patients with COVID‐19 assisted in the Intensive Care Unit (ICU). However, VTE burden among non‐ICU patients hospitalized for COVID‐19 that receive guideline‐recommended thromboprophylaxis is unknown…
DettagliStandard evaluation and management of the patient with suspected or proven cardiovascular complications of COVID-19, the disease caused by severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), is challenging…
DettagliCoronavirus disease 2019 (COVID-19) continues to cause considerable morbidity and mortality worldwide. Case reports of hospitalized patients suggest that COVID-19 prominently affects the cardiovascular system, but the overall impact remains unknown…
DettagliPatients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early reports describe high venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) rates, but data are limited…
DettagliAn ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to the virus SARS-CoV-2, has infected millions of people and remains a threat to many more. Most critically ill patients have respiratory failure and there is an international effort to understand mechanisms and predictors of disease severity. Coagulopathy, characterized by elevations in D-dimer and fibrin(ogen) degradation products (FDPs), is associated with critical illness and mortality in patients with COVID-19…
DettagliPreliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders…
DettagliAlthough COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations…
DettagliThoracic ultrasound seems to adapt to the screening for lung involvement of patients with suspected or ascertained SARS-COVID-19 infection due to its characteristics of easy applicability…
DettagliEmerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of VTE…
DettagliSARS-CoV-2 pneumonia patients present with coagulation disorders and marked susceptibility to thrombosis. However, the exact prevalence of DVT has been poorly investigated while the risk seems increased in ICU patients. Therefore, we decided to perform routine duplex ultrasound examination of the lower limb veins systematically, in order to administer appropriate anticoagulation in all intubated and mechanically ventilated patients with SARS-CoV-2 pneumonia…
DettagliThere is an urgent need to identify patients at high risk during the ongoing coronavirus disease (COVID- 19) pandemic. Whether a history of stroke is associated with increased severity of disease or mortality is unknown…
DettagliIn the very last days of the year 2019a new virus of the coronavirus family, named Sars-Cov-2 was identified as responsible for the outbreak of cases of human pneumonia in Wuhan, China, a condition named Corona Virus Disease of 2019 (COVID-19). This virus displayed a rapid worldwide spread, with rates significantly higher and with much more severe clinical manifestations than those of seasonal influenza virus…
DettagliThe outbreak of a novel coronavirus (COVID-19) with symptoms that mimic bronchitis and other chest infections has created a need for quick diagnosis to prevent disease spread. Traditionally, computed tomography (CT) has been used as the primary method to identify infection and staging of the virus…
DettagliWhen caring for patients with suspected or confirmed COVID-19 (coronavirus disease 2019), especially when involved in procedures that generate aerosol, personal protective equipment (PPE) with full-body coverage is recommended…
DettagliThe diagnostic medical sonography profession is comprised of specialties in abdominal, breast, cardiac, obstetrics, gynecology, musculoskeletal, pediatric, phlebology, vascular, and other emerging clinical areas. These diverse areas of sonography all use ultrasound as the primary technology in their daily work…
DettagliCoronavirus disease (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is responsible for the ongoing 2019–2020 pandemic. Venous thromboembolism (VTE), a frequent cardiovascular and/or respiratory complication among hospitalized patients, is one of the known sequelae of the illness…
DettagliThis case series reports a systematic assessment of deep vein thrombosis among patients in an intensive care unit in France with severe coronavirus disease 2019 (COVID-19)…
DettagliThere has been a recent report of large artery ischaemic stroke among young patients with coronavirus disease 2019 (COVID-19) in the USA. The cause is felt to include coagulopathy and vascular endothelial dysfunction…
DettagliThis Report does not intend to provide a comprehensive state-of-the-art review, but rather a snapshot of this rapid evolving situation, a field undergoing rapid evolution, with a daily flood of scientific publications and non-peer reviewed reports. The preparation of a COVID-19 report in this context is therefore a risky undertaking and the drafters of this document are well aware of their limits…
DettagliLung ultrasound is a reasonable tool for detection of manifestations of COVID-19, to facilitate the division of patients flow of infected with SARS-CoV-2 from those affected by other pathologies…
DettagliThis document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of these patients and provide to up-to-date guidance…
DettagliPeriodico online della Società Italiana di Ecocardiografia e CardioVascular Imaging – numero 34 – marzo 2020 – speciale COVID-19…
DettagliAnnual influenza epidemics are like Minnesota winters — all are challenges, but some are worse than others. No matter how well we prepare, some blizzards take quite a toll. Each year, despite our ef- forts to increase the rates of influenza vaccination in our most vulnerable populations, unpredictable factors largely determine the burden of influenza disease and related deaths…
DettagliThere are many pharmacologic therapies that are being used or considered for treatment of COVID-19. There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature…
DettagliL’infezione da Sars-Cov-2 rappresenta una sfida senza precedenti per la medicina moderna. Gli sforzi fatti per comprendere le caratteristiche microbiologiche del virus e le misure messe in atto per ridurre il numero di contagi hanno portato ad un parziale contenimento della malattia a livello mondiale. In questo breve documento sono contenuti alcuni elementi per l’adeguata gestione del caso sospetto in ambiente ospedaliero e territoriale al fine di ottimizzare manovre di contenimento e gestione del paziente…
DettagliViral epidemics or pandemics of acute respiratory infections like influenza or severe acute respiratory syndrome pose a global threat. Antiviral drugs and vaccinations may be insufficient to prevent their spread…
DettagliOn Mar. 11, 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pan- demic. The worldwide spread of COVID-19 represents a profound threat to human health. Patients with COVID-19 present primarily with fever, cough, and myalgia or fatigue, and sometimes initially with predominantly gastrointestinal symptoms…
DettagliAt a time when Italy and all world is dramatically faced with the challenge of the SARS-Cov-2 infection, hitting many aspects of human civilization, Commissione Salute of the Accademia Nazionale dei Lincei felt that it is part of its social responsibility to provide the society at large with an Executive Summary of the current status of understanding of origin, pathogenesis, and treatment of COVID-19 pandemic…
DettagliCoronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis…
DettagliIn the rapidly evolving management of seriously ill patients affected with coronavirus disease 2019 (COVID-19) there is usually insufficient evidence available to make true practice guidelines. The question responses represent the opinion of a group of venous specialists who have reviewed the currently available evidence and have communicated with specialists in high volume sites in the US and internationally…
DettagliSolid data is lacking, but an emerging body of evidence suggests that COVID-19 may predispose patients to arterial and venous thrombotic disease, and that some of the therapies under investigation may pose distinct drug-drug interactions with common antithrombotic medications…
DettagliWe report five cases of large-vessel stroke in patients younger than 50 years of age who presented to our health system in New York City. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all five patients…
DettagliLa comunità scientifica desidera contribuire al governo di questa emergenza, proponendo un modello di gestione del paziente con ictus cerebrale acuto che tenga conto della nuova realtà epidemiologica e, soprattutto, della rimodulazione del setting in cui gli operatori sanitari, e in particolare i Neurologi coinvolti nella cura del paziente con ictus, sono chiamati ad operare…
DettagliPartendo dalle evidenze presenti in letteratura, lo scopo di questo articolo è analizzare i possibili meccanismi coinvolti nel processo coagulativo a seguito dell’infezione da COVID-19 e quali potrebbero essere le strategie terapeutiche vascolari da poter attuare…
DettagliWe report a case-series of COVID-19 patients with pulmonary embolism (PE) in our institution. Lille University Hospital is the tertiary care center for the North-of-France, the 2nd French region in population density (189 p/km2), also considered as a “metabolic” area with high number of overweight patients. The study was approved by the Institutional data protection authority of Lille University Hospital…
DettagliL’attuale grave epidemia, o forse pandemia, del nuovo coronavirus COVID-19 emerso in Cina a Wuhan alla fine del 2019 ha dimostrato di avere un devastante impatto planetario di salute pubblica. Le implicazioni cardiologiche del coronavirus COVID-19 sono tutt’altro che marginali e costituiscono l’occasione per richiamare l’attenzione del cardiologo sulle rilevanti interazioni tra infezioni da virus respiratori o altri agenti patogeni e rischio cardiovascolare…
DettagliThe present COVID-19 outbreak emphasizes the need for greater awareness of the immediate and long-term cardiovascular implications of viral infection and the significant gaps in knowledge that future research will need to address…
DettagliA relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated…
DettagliSi riprendono le attività: come tutelare noi stessi ed i nostri Pazienti in caso di visita medica od esame diagnostico? Abbiamo imparato dalle nostre stesse esperienze che quasi sin da subito il criterio epidemiologico ha perso ogni significato al fine di individuare persone che fossero state esposte al contagio da Coronavirus…
DettagliL’ecografia è, fra le tecniche di Imaging, quella che comporta la maggiore interazione fra medico e paziente. Purtroppo, in questo momento di emergenza per il diffondersi della infezione da COVID-19, quello che da sempre è l’elemento positivo dell’ecografia diventa un importante elemento potenzialmente negativo determinando, se eseguito non in sicurezza, un aumentato rischio di contagio fra medico e paziente…
DettagliThis statement has been written on behalf of the WFUMB Safety Committee as official guidance with collaboration of experts from various affiliated Federations. Whilst this statement ensures that a consistent approach to infection prevention and safe ultrasound practices are implemented during the COVID-19 pandemic, there may be some operational and organizational differences at the local level…
DettagliLa SIECVI, al pari di altre Società, vista l’importanza del fenomeno sanitario ha deciso di formulare un documento finalizzato a sottolineare l’importanza di una corretta procedura di indicazione ed esecuzione dell’ecocardiogramma in corso di pandemia COVID-19…
DettagliIn relazione alla Pandemia da COVID-19 dichiarata il 10 Marzo 2020, si definiscono le norme di esecuzione degli esami di ultrasonografia vascolare per i professionisti del settore. È stato dimostrato che l’infezione virale viene trasmessa attraverso il contatto ravvicinato e in particolare attraverso droplet, pertanto esiste un rischio elevato di trasmissione tra paziente infetto e medico vascolare esecutore dell’esame e viceversa…
DettagliThe World Health Organization has recently defined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection a pandemic. The infection, that may cause a potentially very severe respiratory disease, now called coronavirus disease 2019 (COVID-19), has airborne transmission via droplets…
Dettagli